Please login to the form below

Not currently logged in
Email:
Password:

Cinqaero

This page shows the latest Cinqaero news and features for those working in and with pharma, biotech and healthcare.

AZ gets EMA green light for severe asthma drug Fasenra

AZ gets EMA green light for severe asthma drug Fasenra

AZ gets EMA green light for severe asthma drug Fasenra. The biologic respiratory treatment will go up against GSK’s Nucala and Teva’s Cinqaero. ... Fasenra (benralizumab) is the third IL-5-targetting drug approved for market after GlaxoSmithKline’s

Latest news

More from news
Approximately 6 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics